MENU
+Compare
IMRA
ETF ticker: NYSE ARCA
AS OF
Jul 25 closing price
Price
$42.52
Change
-$3.74 (-8.08%)

IMRA stock forecast, quote, news & analysis

The investment seeks to provide current income; the fund’s secondary investment objective is to provide exposure to the price return of common shares of MARA Holdings, Inc... Show more

Category: #Trading
IMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
A.I.Advisor
published price charts
Interact to see
Advertisement
A.I.Advisor
a Summary for IMRA with price predictions
Jul 25, 2025

Momentum Indicator for IMRA turns negative, indicating new downward trend

IMRA saw its Momentum Indicator move below the 0 level on July 22, 2025. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 52 similar instances where the indicator turned negative. In of the 52 cases, the stock moved further down in the following days. The odds of a decline are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The Moving Average Convergence Divergence Histogram (MACD) for IMRA turned negative on July 23, 2025. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 23 similar instances when the indicator turned negative. In of the 23 cases the stock turned lower in the days that followed. This puts the odds of success at .

IMRA moved below its 50-day moving average on July 23, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for IMRA crossed bearishly below the 50-day moving average on July 25, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 7 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where IMRA declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

Bullish Trend Analysis

The RSI Indicator entered the oversold zone -- be on the watch for IMRA's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where IMRA advanced for three days, in of 134 cases, the price rose further within the following month. The odds of a continued upward trend are .

IMRA may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

The Aroon Indicator entered an Uptrend today. In of 109 cases where IMRA Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .

A.I.Advisor
published Highlights

Industry description

The investment seeks to provide current income; the fund’s secondary investment objective is to provide exposure to the price return of common shares of MARA Holdings, Inc. (Nasdaq: MARA) (“MARA”), subject to a limit on potential investment gains. The manager seeks to achieve these investment objectives through the use of a synthetic covered call strategy. The manager seeks to provide its synthetic exposure to the price return of MARA through the purchase and sale of a combination of call and put option contracts that utilize MARA as the reference asset. The fund is non-diversified.
View a ticker or compare two or three
IMRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published General Information

General Information

a company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies

Category Trading

Profile
Fundamentals
Details